MERCK & CO, INC. for MERCK & CO INC
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Korea Free Trade Agreement (H.R. 3080); TranPacific Partnership
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Manufacturing MAN
Supply chain safety (no specific bill); pharmaceutical shortages (S. 296, H.R. 2245)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| JEROME MURRAY | — |
Law Enforcement/Crime/Criminal Justice LAW
Tort reform (H.R. 5); human trafficking (H.R. 2759)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
Budget/Appropriations BUD
Deficit Reduction (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Consumer Issues/Safety/Products CSP
Access to over-the-counter medications (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
Medicare/Medicaid MMM
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Animals ANI
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942; S 1577); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Prescription Drug User Fee Act reauthorization (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to immunizations (no specific bills); health literacy (no specific bills); adherence (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.